Cargando…
Remedicalizing cannabis : science, industry, and drug policy /
"When cannabis tincture was withdrawn as a medical product in the UK in 1973, cannabis became regulated solely as an illicit drug. Within a decade cannabis-based drugs were back in the clinic. The UK is one of the biggest producers of medicinal cannabis, but few patients have access to these me...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Montreal ; Kingston ; London ; Chicago :
McGill-Queen's University Press,
[2022]
|
| Colección: | Intoxicating histories ;
3. |
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Understanding Cannabis: Pharmacology, Laboratory Research, and Drug Control, 1964-82
- Cannabis in the Clinic: Clinical Pharmacology and the Therapeutic Applications of Cannabis, 1973-82
- Evidence-Based Policy? The Development of Expert Committees, 1972-82
- Industrializing Cannabis: The Pharmaceutical Industry and the Remedicalization of Cannabis, 1973-2001
- Forces of Necessity: Lay Advocacy and the Remedicalization of Cannabis, 1973-2001
- Establishing Therapeutic Cannabis: The Role of Expert Advice, 1997-2001
- From Anecdotal to Evidence-Based Medicine: The Role of Clinical Trials, 1995-2005
- Accessing Cannabis-Based Medicinal Products (CBMPS), 2009-21.